![]() |
Volumn 41, Issue 1, 2009, Pages 289-291
|
Lung Transplantation in Pulmonary Fibrosis: Challenging Early Outcomes Counterbalanced by Surprisingly Good Outcomes Beyond 15 Years
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
AZATHIOPRINE;
CYCLOSPORIN;
GANCICLOVIR;
IMMUNOSUPPRESSIVE AGENT;
PREDNISOLONE;
VALGANCICLOVIR;
ARTICLE;
CAUSE OF DEATH;
CYTOMEGALOVIRUS INFECTION;
FIBROSING ALVEOLITIS;
HUMAN;
KAPLAN MEIER METHOD;
LUNG DISEASE;
LUNG FIBROSIS;
LUNG GRAFT REJECTION;
LUNG SARCOIDOSIS;
LUNG TRANSPLANTATION;
LYMPHANGIOLEIOMYOMATOSIS;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TREATMENT OUTCOME;
COHORT STUDIES;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTONIC SOLUTIONS;
LUNG TRANSPLANTATION;
ORGAN PRESERVATION;
ORGAN PRESERVATION SOLUTIONS;
PULMONARY FIBROSIS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
SURVIVORS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 60649100474
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2008.10.042 Document Type: Article |
Times cited : (51)
|
References (8)
|